Log in
Enquire now
‌

US Patent 10488420 Methods of diagnosing and predicting renal disease

Patent 10488420 was granted and assigned to Joslin Diabetes Center (company) on November, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Current Assignee
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10488420
Date of Patent
November 26, 2019
Patent Application Number
15711073
Date Filed
September 21, 2017
Patent Citations Received
‌
US Patent 11885813 Methods of diagnosing and predicting renal disease
0
Patent Primary Examiner
‌
Catherine S Hibbert
Patent abstract

This disclosure relates to methods of diagnosing and predicting renal disease, using one, two, or more biomarkers, including sTN-FR1, sTNFR2, sFAS, TNF, and IL-6.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10488420 Methods of diagnosing and predicting renal disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.